AbbVie (ABBV) Acquisitions (2012 - 2025)
AbbVie (ABBV) posted quarterly Acquisitions of $204.0 million for Q1 2025, down 97.78% year-over-year from $9.2 billion in Q1 2024, and down 97.54% quarter-over-quarter from $8.3 billion in Q3 2024.
AbbVie (ABBV) Acquisitions (2012 - 2025) Analysis & Trends
AbbVie (ABBV) has reported Acquisitions for 10 consecutive years, with $204.0 million the latest figure, recorded in Q1 2025.
- In Q1 2025, Acquisitions fell 97.78% year-over-year to $204.0 million; the TTM figure through Dec 2025 stood at $204.0 million (down 98.83% YoY), while the FY2025 annual figure was $204.0 million, down 98.83% from the prior year.
- Acquisitions retreated to $204.0 million in Q1 2025 per ABBV's latest filing, from $8.3 billion in the prior quarter.
- Across five years, Acquisitions topped out at $9.2 billion in Q1 2024 and bottomed at $204.0 million in Q1 2025.
- Historically, Acquisitions has averaged $4.6 billion across 3 years, with a median of $4.4 billion in 2021.
- Annual changes were most pronounced in 2021 — Acquisitions surged 330.33% — and 2025, when it sank 97.78%.
- AbbVie's Acquisitions stood at $525.0 million in 2021, then soared by 1479.81% to $8.3 billion in 2024, then slumped by 97.54% to $204.0 million in 2025.
- Business Quant data shows ABBV's Acquisitions at $204.0 million in Q1 2025, $8.3 billion in Q3 2024, and $9.2 billion in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.36 Bn | 632.60 Bn | 17.26 Bn | -17.24 Bn |
| 2 | AbbVie | 470.47 Bn | 463.90 Bn | 12.70 Bn | - |
| 3 | Merck | 379.81 Bn | 372.67 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 303.09 Bn | 295.40 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 258.57 Bn | 253.67 Bn | 12.86 Bn | - |
| 6 | Amgen | 237.19 Bn | 223.20 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 182.88 Bn | 179.70 Bn | 6.22 Bn | 11.21 Bn |
| 8 | Pfizer | 161.00 Bn | 149.30 Bn | 10.94 Bn | - |
| 9 | Gsk | 105.89 Bn | 101.73 Bn | 8.24 Bn | - |
| 10 | Sanofi | 55.24 Bn | 47.86 Bn | 10.79 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 204.00 Mn |
| Sep 30, 2024 | 8.29 Bn |
| Mar 31, 2024 | 9.20 Bn |
| Dec 31, 2021 | 525.00 Mn |
| Dec 31, 2020 | 122.00 Mn |
| Jun 30, 2017 | -63.00 Mn |
| Mar 31, 2017 | 63.00 Mn |
| Dec 31, 2016 | 18.00 Mn |
| Sep 30, 2016 | 22.00 Mn |
| Jun 30, 2016 | 2.43 Bn |
| Mar 31, 2016 | 28.00 Mn |
| Jun 30, 2015 | 10.75 Bn |
| Mar 31, 2015 | 736.00 Mn |
| Dec 31, 2014 | 50.00 Mn |
| Sep 30, 2014 | 555.00 Mn |
| Dec 31, 2013 | 47.00 Mn |
| Sep 30, 2013 | 224.00 Mn |
| Jun 30, 2013 | 134.00 Mn |
| Dec 31, 2012 | -92.00 Mn |
| Jun 30, 2012 | 109.00 Mn |